Niche Focus MOD3 Pharma specializes in OINDP, offering stage-appropriate solutions for early phase clinical supplies, which presents a targeted upsell opportunity to biotech firms advancing inhaled or nasal therapies.

CMCs Expertise With decades of CMC experience, MOD3 can position itself as a trusted partner to streamline formulation to clinic transitions, helping sponsors reduce risk, delay, and cost in early trials.

Pilot Scale Capabilities Capabilities in spray drying, semi-automated filling, and nasal delivery devices enable quick onboarding for companies needing small-batch, single-dose to multidose nasal products for Phase 1/2 trials.

Strategic Fit Smaller to mid-sized pharma and biotech companies seeking CRO-like scale with specialized OINDP know-how can leverage MOD3 to fill critical early-phase supply gaps without engaging larger contract manufacturers.

Growth Readiness Revenue in the low-to-mid millions and a clear focus on inhalation/nasal products suggest an opportunity to pursue partnerships around program acceleration, risk mitigation, and cost containment as sponsors de-risk early programs.